To include your compound in the COVID-19 Resource Center, submit it here.

Boehringer, Vanderbilt target MCL1

Boehringer Ingelheim GmbH (Ingelheim, Germany) and Vanderbilt

Read the full 79 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE